Skip to main navigation Skip to search Skip to main content

Choosing the best first line oral drug agent in patients with pulmonary hypertension: Evidence from a network meta-analysis

  • Giuseppe Biondi-Zoccai
  • , Fabrizio D'Ascenzo*
  • , Margherita Cannillo
  • , Nicky J. Welton
  • , Walter Grosso Marra
  • , Pierluigi Omedè
  • , Daniela Libertucci
  • , Enrico Fusaro
  • , Michele Capriolo
  • , Jacopo Perversi
  • , Francesco Fedele
  • , Giacomo Frati
  • , Massimo Mancone
  • , James J. Dinicolantonio
  • , Carmine Dario Vizza
  • , Claudio Moretti
  • , Fiorenzo Gaita
  • *Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)4336-4338
Number of pages3
JournalInternational Journal of Cardiology
Volume168
Issue number4
DOIs
Publication statusPublished - 9 Oct 2013

Keywords

  • Clinical end point
  • Oral therapy
  • Pulmonary arterial hypertension

Cite this